Marc Dubourdeau, PhD, is the Chief Executive Officer (CEO) of Ambiotis. He obtained a PhD degree in Immunology from the University Paul Sabatier (Toulouse, France) and a Master’s Management degree from the ESC Toulouse (France).
Prior to Ambiotis’ creation, Marc Dubourdeau was working for the Pasteur Institute (Paris, France) where he was investigating the mechanisms of the inflammatory process in various infectious diseases.
Ambiotis scientific team
Dynamic and highly skilled PhD, research engineers and higher technicians are working for the scientific board of Ambiotis.
Strategic advisory board
Dr Nathalie Vergnolle (Research Director INSERM)
Dr Michel Chignard (Senior Research Director INSERM, Inflammatory Mediators Expert),
Pr Jean-Paul Latgé (Research Laboratory Director, Aspergillus Unit, Institut Pasteur),
Pr Laurent Alric (Chief of Internal Medicine, Gastrointestinal Troubles Expert),
Dr Yves Bonhomme (former Chief Scientific Officer, MerckLipha).